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Male gender is protective against multiple sclerosis and other T-cell-mediated autoimmune
diseases. This protection may be due, in part, to higher androgen levels in males. Androgen
binds to the androgen receptor (AR) to regulate gene expression, but how androgen protects
against autoimmunity is not well understood. Autoimmune regulator (Aire) prevents
autoimmunity by promoting self-antigen expression in medullary thymic epithelial cells, such
that developing T cells that recognize these self-antigens within the thymus undergo clonal
deletion. Here we show that androgen upregulates Aire-mediated thymic tolerance to protect
against autoimmunity. Androgen recruits AR to Aire promoter regions, with consequent
enhancement of Aire transcription. In mice and humans, thymic Aire expression is higher in
males compared with females. Androgen administration and male gender protect against
autoimmunity in a multiple sclerosis mouse model in an Aire-dependent manner. Thus,
androgen control of an intrathymic Aire-mediated tolerance mechanism contributes to
gender differences in autoimmunity.
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M
ales are at lower risk for many autoimmune diseases
compared with females. In multiple sclerosis, for
example, the sex ratio of females to males exceeds 3:1
(ref. 1). This gender imbalance may reflect higher androgen levels
in males, since androgen protects against autoimmunity in mice
and humans (refs 2–4); reviewed in ref. 5). Biologically active
androgens can exert their effects by binding to the androgen
receptor (AR) to regulate target gene transcription. The
identity of androgen/AR-regulated immune genes that confer
autoimmune protection, however, is not known.
In the thymus, the autoimmune regulator (Aire) gene enforces
T-cell self-tolerance in part by promoting expression of tissue-
specific antigens (TSAs) in medullary thymic epithelial cells
(mTECs; ref. 6; reviewed in ref. 7). Developing thymocytes that
recognize these TSAs with high affinity undergo negative
selection, thus preventing the release of self-reactive T cells into
the periphery. Aire may also prevent autoimmunity through the
additional mechanisms, such as promoting regulatory T-cell
development8 and expression of chemokines important in
mediating T-cell negative selection9. The critical role for Aire in
preventing autoimmunity is highlighted by the development of
spontaneous, multi-organ autoimmune disease in Aire-deficient
humans and mice. Homozygous Aire mutations in humans
result in autoimmune polyendocrinopathy syndrome type 1
(or autoimmune polyendocrinopathy candidiasis ectodermal
dysplasia), a disease that predisposes to a constellation of
T-cell-mediated autoimmune manifestations10. In parallel, homo-
zygous Aire mutations in mice result in increased frequency
of self-reactive T cells in the periphery and T-cell-mediated
destruction of multiple organs. Thus, Aire is integral in main-
taining T-cell tolerance.
While complete loss of Aire function results in autoimmune
disease, quantitative decreases in Aire also predispose to auto-
immunity. Several lines of evidence suggest that Aire regulation of
T-cell tolerance is dose dependent and non-binary. First,
mutations that quantitatively decrease Aire expression11 or
function12 predispose to autoimmunity. Second, Aire expression
levels are highly variable between individuals in the general
population and strongly correlate with the TSA expression
levels13. Quantitative decreases in Aire-mediated TSA expression
in the thymus, furthermore, predict the development of
autoimmunity14,15. Third, Aire polymorphisms in humans that
incrementally decrease Aire expression are associated with
increased development of autoimmune disease16. Together,
these findings suggest that factors that quantitatively regulate
Aire expression may determine autoimmunity predisposition.
On the basis of these findings, we hypothesized that androgen/
AR complexes may upregulate Aire expression to protect against
autoimmune disease. In support of this hypothesis, we show that
male mice and humans express increased Aire in the thymus.
Aire expression in male mice was reduced with castration and
genetic AR deficiency, suggesting a role for testicular androgen
and AR in upregulating Aire in males. Consistent with this,
androgen administration increased thymic Aire expression
in vitro and in vivo. Finally, we show that androgen administra-
tion and male gender protected against autoimmunity in a mouse
model of multiple sclerosis through an Aire-dependent mechan-
ism. Together, these results suggest that androgen regulation of
the intrathymic Aire tolerance mechanisms alters predisposition
to autoimmunity.
Results
Males express increased Aire in human and mouse thymus.
Males are protected from the development of multiple auto-
immune diseases compared with females17. Since Aire plays a
critical role in protecting from autoimmunity, we hypothesized
that increased androgen in males may upregulate Aire expression
to contribute to this protection. To test this, we first compared
thymic Aire expression in male versus female subjects, using
human thymus tissue removed from infants (o6 months of age)
during the course of cardiac surgery. Human infants in the first
6 months of life undergo ‘mini-puberty’, with high circulating
androgen levels in male infants18,19. Thus, thymus tissue
in male infants during this period is exposed to high androgen
levels. Relative Aire messenger RNA (mRNA) expression was
determine by quantitative PCR with reverse transcription
(RT–PCR) and normalized to cytokeratin 5 (KRT) 5, a house-
keeping gene expressed by thymic medulla. On average, male
thymus expressed higher levels of Aire mRNA compared with
female thymus (Fig. 1a). When human subjects were paired by age,
Aire expression was consistently higher in the male thymus
samples (Fig. 1b). In parallel, we flow-sorted mTECs from male
and female thymus of 6-week-old adult mice and compared Aire
mRNA expression. mTECs from male mice expressed higher
mRNA levels of Aire (Fig. 1c). These differences were not due to
gross alterations in thymic epithelial numbers, since absolute
numbers and frequency of mTECs by flow cytometry were
unchanged between males and females (Fig. 1d). To compare Aire
protein expression, we performed immunofluorescent staining of
thymic sections from male and female mice. Male thymic sections
showed a modest but significant increase in Aire-expressing
(Aireþ ) cells per KRT5þ thymic medullary area (Fig. 1e). Because
Aire is expressed largely in differentiated mTECs that express high
levels of MHCII (mTEChi; (ref. 20)), this increase could be either
due to an increased proportion of mTECs that are mature (and
therefore express Aire) or to an increased Aire expression per
mature mTEC. To distinguish between these two possibilities, we
compared the frequency of mTEChi cells by flow cytometry. No
differences in mTEChi frequencies were noted between males and
females (Fig. 1f). Together, these findings suggest increased Aire
expression per mTEC at the mRNA and protein level.
In addition, mTECs from male mice expressed higher mRNA
levels of Aire-regulated TSAs. We utilized RNA sequencing to
obtain a global representation of the mTEC transcriptome in
6–8-week-old male versus female mice. Among the 2,760
Aire-upregulated transcripts with detectable transcripts in our
samples21, 1,721 (63%) were higher in mTECs from males
compared with females (Fig. 2a). In addition, log2fold change
of male over female expression levels was higher for Aire-
upregulated genes21 compared with Aire-independent genes
(P¼ 3.17e 15; unpaired Student’s t-test; Fig. 2b), which
suggests that male gender has a generally positive impact on
the Aire-regulated transcripts. Of the top, seven genes induced in
males (false discovery rateo0.05), four genes were located on the
Y chromosome, which provided internal validation for this
comparison between the genders. Of the remaining genes, all
three have been reported to be Aire regulated21,22 (Fig. 2c). We
next utilized quantitative RT–PCR to compare expression levels
of specific Aire-regulated TSAs. Quantitative RT–PCR analysis of
the Aire-regulated TSAs insulin, tyrosinase, TRP-1, Spt-1, Reg3b
and OBP1a showed higher TSA expression in male mTECs6,23,24
(Fig. 2d), whereas expression of the Aire-independent TSAs
Silver, Krt10, Csn2, Gad1, FABP9 and Resp18 (refs 23–25) was
similar between male and female mTECs (Fig. 2e).
Multiple factors may contribute to the gender difference in
Aire expression, including chromosomal, environmental and
hormonal factors5. We chose to focus on the potential effects of
androgen on Aire expression because of the strong existing
evidence that androgen is protective against autoimmunity5. To
test the possibility that testicular androgen may contribute to
increased male Aire expression, we castrated 2-week-old C57BL/6
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wild-type (WT) male mice and measured Aire expression levels 2
weeks later. Castration decreased Aire mRNA expression in
thymic stromal cells compared with intact, age-matched males
(Fig. 2f), suggesting that testicular androgen increases Aire
expression in males. In addition, we compared Aire mRNA levels
in thymic stroma of testicular feminized (ARTfm/Y) mice versus
WT male littermate controls. ARTfm/Y mice have a sponta-
neously occurring, inactivating AR mutation, and therefore are
insensitive to androgen. Aire mRNA levels were lower in thymic
stroma of ARTfm/Y mice compared with WT male littermate
controls (Fig. 2g), suggesting that AR is important in increasing
Aire expression in male mice. In addition, mRNA levels of two
Aire-regulated TSAs, insulin and Spt-1 (ref. 6), were also lower in
thymic stromal cells of ARTfm/Y mice (Fig. 2h). AR effect was
specific to Aire-regulated TSAs, since expression of Silver, an
Aire-independent TSA23, was unchanged between the two strains.
Together, these findings suggest that AR-dependent testicular
androgen action is important in increasing Aire expression in
male mice.
DHT increases Aire expression in mouse and human thymus.
Intrigued by these findings, we tested whether androgen upre-
gulates Aire expression in vitro. We compared Aire expression
in primary thymic stromal cells cultured for 6 h with
dihydrotestosterone (DHT), a potent testosterone metabolite that
is not subject to conversion to oestradiol, or vehicle control. DHT
induced a significant increase in Aire mRNA expression in
human thymic stromal cells from both male and female subjects
(Fig. 3a), with a larger effect in cells of males compared with
females. Similar increases in Aire mRNA expression were seen
with mouse thymic stromal cells, with a more pronounced effect
with male cells (Fig. 3b). Finally, the addition of flutamide, an AR
antagonist, blocked DHT induction of Aire in thymic stromal
cells of male mice, which suggests that DHT upregulation of Aire
expression was AR dependent (Supplementary Fig. 1).
In addition, we determined the effect of androgen on LNCaP
cells, an epithelial cell line that expresses endogenous AR. LNCaP
cells do not express Aire at baseline but can be induced to express
Aire with 5-aza-20-deoxycitidine (5-Aza), a demethylating agent,
and trichostatin, a histone deacetylase inhibitor (Supplementary
Fig. 2), as previously described26,27. Addition of 10 nM DHT
further increased Aire mRNA expression (Fig. 3c), suggesting that
androgen promotes Aire transcription in this cell line.
To determine the androgen effects on Aire expression in vivo,
we implanted 2-week-old male C57BL/6 WT mice with DHT
pellets for 2 weeks or subjected mice to a sham implantation. By
quantitative RT–PCR analysis, DHT treatment increased Aire
mRNA expression of thymic stromal cells compared with sham
treatment (Fig. 3d). Furthermore, DHT treatment also increased
mRNA expression of two Aire-regulated TSAs, Spt-1 and TRP-1
(refs 6,23; Fig. 3e). Because Aire expression was compared using
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Figure 1 | Male thymus expresses increased Aire in humans and mice. (a) Relative Aire mRNA expression in human thymus of male and female infants
(o6 months of age). Relative expression was measured by quantitative RT–PCR relative to cytokeratin 5, a thymic medulla marker. n¼6 for each group.
Error bars represent s.d. (b) Relative Aire mRNA expression in a displayed as age-matched male–female pairs. Ages are indicated at the right of each pair.
(c) Relative mRNA expression of Aire in sorted mTECs from male versus female thymi of 6-week-old mice. A total of 4–10 mice were pooled per sample.
Data shown are representative of four independent experiments. Error bars represent s.d. (d) Top: absolute numbers of total mTECs (CD45 MHCIIþ ,
Ly51low) by flow cytometry in 8-week-old male versus female mice. Bottom: frequency of total mTECs within CD45 MHCIIþ stromal cells. Thymi from
pools of 4 mice per group were used in each replicate, with three replicates total. (e) Left: representative immunofluorescent images of 8-week-old male
and female thymus sections stained with anti-Aire (green) and anti-cytokeratin 5 (K5) antibodies. Right: quantification of Aireþ cells per K5þ area for
females and males. n¼4 mice per group. Error bars represent s.e.m. (f) Ratio of mTEChi (CD45 MHCIIhigh, Ly51low) to mTEClo (CD45 MHCIIlow,
Ly51low) in males versus females. n¼ 3 for each group. Error bars represent s.e.m. For all data sets, unpaired Student’s t-test was used for comparisons
except in b, in which paired Student’s t-test was used. *Po0.05. NS, not significant.
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thymic stromal cells, DHT could either be increasing the
proportion of mature mTECs that express Aire or directly
increasing Aire expression within mature mTECs. To resolve
whether DHT might be altering thymic epithelial cell (TEC)
subset numbers, we subjected 3-week-old male mice to
sham procedure or DHT pellet insertion and determined the
frequency and absolute number of thymic epithelial subsets by
flow cytometry 1–3 weeks later. No differences were seen in the
frequency of mTECs (%CD45 MHCIIþ Ly51low), cortical
TECs (%CD45 MHCIIþ Ly51high), mTEChi (%CD45
MHCIIhigh Ly51low) or mTEClo (%CD45 MHCIIlow Ly51low;
Supplementary Fig. 3a,b). Furthermore, the ratio of mTEChi
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to mTEClo was unchanged in sham- and DHT-treated
mice (Supplementary Fig. 3c), suggesting that DHT is not
increasing the proportion of mature MHCIIhi mTECs.
Of note, the absolute numbers of mTEChi and cortical TEC
populations were significantly decreased with DHT treatment,
and similar trends were seen with total mTEC and mTEClo
populations, although these differences did not quite reach
statistical significance (Supplementary Fig. 3d). Together, these
findings suggest that DHT treatment has a global effect on
stromal cell numbers, without disproportionately affecting a
particular subpopulation. Thus, it is unlikely that the increased
Aire expression seen in DHT-treated mice is due to an increased
frequency of the differentiated mTEC subset but instead is due to
increased Aire expression in mTECs. In line with this, DHT
treatment increased Aire and Spt-1 mRNA expression in sorted
mTEChi cells (Supplementary Fig. 4). Together, these findings
provide evidence that DHT increases Aire and TSA expression in
mTECs.
Given the increased TRP-1 expression in DHT-treated males,
we asked whether DHT treatment would result in more efficient
negative selection of TRP-1-reactive T cells. We utilized TRP-1
T-cell receptor (TCR) transgenic (Tg) mice to test this, since CD4
single-positive (SP) thymocytes in these mice normally undergo
Aire-dependent negative selection23,28,29. Two-week-old TRP-1
TCR Tg male mice were treated with acyline, a gonadotropin-
releasing hormone antagonist, to minimize endogenous androgen
production30, then implanted with DHT pellets for 4 weeks or
subjected to sham implantation. Representative flow plots with
the frequencies of CD4SP, double-positive, CD8SP and double-
negative cells among thymocytes are shown in Fig. 3f. With
sham treatment, 1.88% of thymocytes were CD4SP cells in
Aire-sufficient (WT) mice. This low frequency reflects
Aire-dependent TRP-1 TCR Tg thymocyte negative selection
without the addition of exogenous DHT. With DHT treatment,
the CD4SP frequency further decreased to 0.54% suggesting that
DHT enhances Aire-mediated negative selection. Quantification
of frequency of CD4SP cells (n¼ 4 for sham, n¼ 6 for DHT
treated) is shown in Fig. 3g. DHT treatment also decreased the
absolute numbers of CD4SP cells. No significant differences were
seen in double-negative, double-positive and CD8SP
subpopulations (Fig. 3f,g). Consistent with increased clonal
deletion, increased frequency of apoptotic, annexin V-positive
CD4SP thymocytes was seen in DHT-treated mice (Fig. 3h). An
alternative explanation to consider is that DHT is directly toxic to
thymocytes. This possibility was tested by incubating thymocytes
for 6 h in either vehicle control or 10 nM DHT. The frequency of
annexin Vþ cells was not different in the two groups, which
suggests that DHT is not acting directly on thymocytes
(Supplementary Fig. 5). A caveat to this experiment, however,
is that apoptosis was compared in a short-term in vitro culture
system, which may not reflect the thymocyte environment in vivo.
Additional evidence that DHT is not directly acting on
thymocytes is provided by a previous report utilizing
haematopoietic chimeras in which AR is expressed only on
haematopoetic cells and not in the non-haematopoietic cells, such
as TECs31. DHT treatment of these chimeras did not alter the
frequencies of thymocytes subsets, suggesting that AR expression
on thymocytes does not affect thymocyte development. Together,
these data suggest that androgen enhances Aire expression in
mTECs, with subsequent increase in TSA expression and T-cell
negative selection.
Androgen activation targets AR to the Aire promoter. We next
sought to determine the molecular mechanism by which andro-
gen increases Aire expression in the thymus. AR is expressed in
the thymus, with highest levels in TECs31,32. More specifically,
AR is expressed in multiple TEC subsets, including the
MHCIIhigh mTEC (mTEChi) population33. As noted above,
mTEChi cells are of special interest because Aire-expressing
(Aireþ ) mTECs are highly enriched in this subset20. To verify
that AR protein is expressed by Aireþ cells, we performed
immunofluorescent staining of mouse thymic tissue for AR and
Aire. As expected, Aire was restricted to the nucleus of thymic
medullary cells (Fig. 4a). AR was present in the nucleus as well as
the cytoplasm of thymic medullary cells (Fig. 4a), and most
Aireþ cells co-expressed AR (Fig. 4a,b). A high degree of AR and
Aire co-expression was noted in thymic medulla of male and
female mice (Fig. 4b). Given these data (Fig. 4a; ref. 33), we
hypothesized that androgen/AR complexes may directly regulate
Aire transcription through their interaction with the Aire
promoter.
Analysis of the human AIRE gene 50 flanking region using
PROMO software revealed 14 potential AR-binding elements in a
2.8-kb region (Fig. 4c). To determine whether androgen/AR
complex accumulates at Aire promoter regions, we performed AR
chromatin immunoprecipitation in LNCaP cells. As described
previously (Fig. 3c), LNCaP cells endogenously express AR and
can be induced to express Aire with 5-Aza and trichostatin26,27.
In the presence of DHT, AR was selectively enriched at three Aire
promoter regions that were predicted to contain AR-binding sites
(position  2,916 to  2,643,  1,130 to  867 and  383 to
 164; Fig. 4d). These findings suggest that androgen activation
results in AR accumulation at the Aire promoter.
We next utilized a reporter system in human embryonic
kidney 293T (HEK293T) epithelial cells to delineate further how
androgen interacts with the Aire promoter. HEK293T cells were
transfected with pAP1235, an Aire reporter construct comprised
of a human AIRE gene 50 flanking region (position  1,235 to
þ 1 relative to translational start) in front of luciferase26.
This 50 flanking region is sufficient to drive Aire transcrip-
tional activity28 and contains nine predicted AR-binding
Figure 2 | Male thymus expresses increased Aire-regulated TSAs in mice. (a) Heatmap of Aire-upregulated genes. Extreme left and right columns:
expression of genes (log2RPKM) shown to be upregulated in Aire wild-type (WT, left) compared with Aire knockout mTECs (right) in ref. 21. Middle two
columns: expression of Aire-upregulated genes in mTECs of males (left) compared with females (right). Left bar demarcates Aire-upregulated genes that
are increased in male mTECs (63%). (b) Box plot of average fold change (male over female) for expression of Aire-independent versus Aire-dependent
genes in which message was detected. *P¼ 3.17e 15. (c) List of top seven genes upregulated in males (FDRo0.05). RNA for sequencing was obtained
from flow-sorted mTECs from male and female mice. Ten mice were pooled per replicate with two replicates per group. (d,e) Relative mRNA expression of
TSAs in sorted mouse mTECs from male versus female thymic stroma. Six Aire-dependent TSAs ((d) insulin, Spt-1, tyrosinase, TRP-1, Reg3b and Obp1a)
and six Aire-independent TSAs ((e) Silver, Krt10, Csn2, Gad1, Fabp9 and Resp18) were tested. A total of 4–10 mice were pooled per sample. Data shown
are representative of two independent experiments. (f) Relative Aire mRNA expression in thymic stromal cells from castrated versus unmanipulated
(intact) male mice measured by quantitative RT–PCR. (g,h) Relative Aire (g) and TSA (h) (insulin, Spt-1 and Silver) mRNA expression in isolated thymic
stroma from AR-deficient testicular feminized ARTfm/Y (Tfm) mice or WTmale littermate controls measured by quantitative RT–PCR. For (f–h), three mice
were pooled for each sample, and representative of two independent experiments are shown. Thymic stromal cells were used as starting material. For
(d–h), unpaired Student’s t-test was used for comparisons. For (d–h), error bars represent s.d. *Po0.05. FDR, false discovery rate; NS, not significant.
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elements (Fig. 4e). An AR expression construct was also
transfected into HEK293T cells because HEK293T cells do
not express endogenous AR34. In co-transfected HEK293T
cells, DHT strongly induced AIRE promoter activity in a dose-
dependent manner (Fig. 4e). Importantly, mutagenesis of
predicted AR-binding sites in the Aire 50 flanking promoter
region abolished AIRE promoter activity (Fig. 4f; Supplementary
Table 1). These findings suggest that androgen/AR-mediated
Aire upregulation requires the presence of AR-binding sites.
Moreover, transfection of a mutant AR construct (ARD538–614)35
in which AR’s DNA-binding region is deleted also
abolished AIRE promoter activity. Thus, AR’s DNA-binding
region is required to promote Aire expression. Together,
these findings suggest that androgen/AR complexes may
directly interact with the Aire promoter to upregulate Aire
transcription.
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Androgen decreases EAE severity in an Aire-dependent manner.
Since DHT upregulates Aire expression, we tested whether
androgen upregulation of Aire may protect against autoimmune
disease. We utilized the experimental autoimmune encephalitis
(EAE) mouse model of multiple sclerosis that can be induced by
active immunization with Myelin oligodendrocyte glycoprotein
(MOG)35–55 peptide. MOG EAE was attractive as an experimental
system because androgen administration has been shown to
ameliorate the severity of MOG EAE4. Whether the protective
effect of androgen is dependent on Aire, however, is not known.
We hypothesized that androgen protects from MOG EAE by
upregulating Aire expression, which subsequently increases
thymic MOG expression to enforce deletion of MOG-reactive
T cells. To test this hypothesis, we first verified that Aire regulates
MOG antigen expression in the thymus by comparing MOG
expression in sorted mTECs from Aire-deficient versus WT mice.
Aire-deficient mice, harbouring a dominant Aire G228W
mutation (AireGW/þ mice)12, expressed less MOG in mTECs
than WT controls (Fig. 5a). This finding confirmed a previous
report that Aire controls MOG expression in the thymus36.
Furthermore, incubation of thymic stroma from WT male mice
in 10 nM DHT induced MOG mRNA expression (Supplementary
Fig. 6).
To test whether androgen protection is Aire dependent, we
treated male WT and AireGW/þ mice with DHT or vehicle
control for 4 weeks before immunization with MOG35 55
peptide. As expected4, DHT-treated WT mice had milder
clinical disease than sham-treated controls (Fig. 5b, left;
Supplementary Table 2). In contrast, no differences in clinical
EAE severity were seen in DHT-treated or sham-treated
AireGW/þ mice (Fig. 5b, right; Supplementary Table 2),
suggesting that the protective effect of androgen is Aire
dependent.
In WT mice, DHT administration was associated with
decreased inflammatory foci and demyelination in the
lumbar spine (Fig. 5c,d, top panels); in AireGW/þ mice, on
the other hand, DHT treatment did not have an effect (Fig. 5c,d,
bottom panels). In addition, DHT administration decreased
splenocyte interleukin-2 (IL-2) and IL-17 inflammatory cyto-
kine secretion in WT mice (Fig. 5e). In contrast, DHT treatment
did not have an effect in AireGW/þ mice (Fig. 5e). Together,
these findings suggest that the protective effect of DHT on
MOG-induced EAE requires Aire. Of note, our data does not
rule out that androgen decreases EAE severity through an
indirect, Aire-mediated mechanism. For instance, since
Aire affects thymic regulatory T-cell (Treg) development8,
androgen may promote Treg suppressive function in WT
(Aire sufficient) mice without affecting thymic Tregs in
Aire-deficient mice.
Male gender protects against EAE in an Aire-dependent manner.
Our data suggest that male gender is associated with increased
Aire and TSA expression in the mouse thymus (Figs 1c and 2a–c).
In line with this, sorted mTECs from male C57BL/6 WT mice
expressed increased MOG mRNA compared with female mice
(Fig. 6a). Given this increased MOG expression in male versus
female thymus, we next asked whether male gender also protects
against EAE in an Aire-dependent manner. In WT mice, clinical
disease was more severe in females compared with males (Fig. 6b,
left; Supplementary Table 3). In Aire-deficient (AireGW/þ ) mice,
on the other hand, clinical disease was not different between the
two groups (Fig. 6b, right; Supplementary Table 3), suggesting
that amelioration of autoimmunity in males required Aire.
In WT mice, male gender was associated with decreased the
numbers of inflammatory foci and the areas of demyelination in
the lumbar spine (Fig. 6c,d, top). In AireGW/þ mice, in contrast,
these differences were not seen. Finally, male gender was
associated with decreased splenocyte inflammatory cytokine
production in WT mice (Fig. 6e). These differences were
abolished in Aire-deficient AireGW/þ mice (Fig. 6e). Together,
these results suggest that male gender is protective against
MOG-induced EAE and that this protection is dependent on
Aire.
Discussion
Gender bias in multiple sclerosis and other autoimmune diseases
is well-documented (reviewed in ref. 5). What underlies these
gender differences, however, is not clear. Gender differences in
autoimmunity have been attributed to multiple factors, including
differences in sex steroid hormone levels. In particular, increased
androgen levels are associated with protection from
autoimmunity, although the mechanism(s) that confer this
protection are not clear. In this study, we provide evidence that
increased androgen levels in males may protect from
autoimmunity by maintaining higher levels of thymic Aire
expression (Supplementary Fig. 7). By ‘dialing up’ the level of
Aire, androgen also upregulates Aire-mediated TSA expression
and negative selection of self-reactive T cells. Androgen therefore
reinforces a central tolerance barrier, which limits the release of
autoimmune T cells into the periphery.
The mechanisms by which androgen protects against auto-
immunity have been the subject of intense interest. Androgen has
been proposed to avert autoimmunity by upregulating TGF-beta
production in thymic stromal cells37. Recently, two studies
have reported that androgen regulation of gut microbiota
contributes to gender differences in autoimmunity predis-
position in mice2,3. Androgen regulation of bone marrow
stromal cells and subsequent transforming growth factor-beta
Figure 3 | Androgen enhances Aire transcription, TSA expression and negative selection of self-reactive T cells. (a) Relative AIRE mRNA expression
levels in male and female thymic stromal cells incubated with 10 nM DHT or vehicle control ( ) for 6 h. Cells were from o1-week-old paired human
subjects. Data shown are representative of at least three representative experiments. (b) Relative Aire mRNA expression levels in thymic stroma of
6-week-old male and female mice incubated with 10 nM DHT or vehicle control ( ) for 6 h. Four mice were pooled per group, and data shown are
representative of at least two independent experiments. (c) Relative Aire mRNA expression in LNCaP cells pretreated with indicated concentrations of
5-Aza and 100ngml 1 trichostatin in the presence of 10 nM DHT (gray bars) or vehicle control (black bars) for 8 h. Data shown are representative of two
independent experiments. (d,e) Relative Aire (d) and TSA (e) (Spt-1 and TRP-1) mRNA expression in isolated thymic stroma from mice treated with DHT
pellets or sham implant procedure. (f) Two-week-old TRP-1 TCR Tg RAG / male mice were treated with 20mg kg 1 acyline to minimize endogenous
androgen production and implanted with DHT pellets or sham treated for 4 weeks total. Representative flow cytometry plots of thymocytes with
frequencies of CD4 single-positive (CD4SP), double-positive (DP), CD8 single-positive (CD8SP) and double-negative (DN; clockwise, starting from left)
populations shown in DHT-treated versus sham-operated male mice. (g) Average frequencies (top) and absolute numbers (bottom) of thymocyte
subpopualtions as indicated for DHT-treated (n¼4) and sham-operated (n¼6) male mice. (h) Flow cytometric analysis of annexin V levels in CD4 single-
positive thymocytes. Representative flow plot (left) and cumulative data (right) are shown. For all data sets, unpaired Student’s t-test was used for
comparisons. Error bars represent s.e.m. *Po0.05. NS, not significant.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11350 ARTICLE
NATURE COMMUNICATIONS | 7:11350 | DOI: 10.1038/ncomms11350 | www.nature.com/naturecommunications 7
(TGF-beta) production has also been proposed as a mechanism
by which androgen protects against autoimmunity31. In line with
this, androgen may also exert anti-inflammatory effects by
decreasing inflammatory cytokine and growth factor production
by prostate stromal cells38, and by repressing transcription factors
important in peripheral immune cell activation39. Our finding
that androgen regulates Aire expression in mTECs represents a
distinct pathway for androgen-mediated protection against
autoimmunity, which is not mutually exclusive of the
previously reported mechanisms. It has been reported that Aire
is required early, but is dispensable later in life40. Early in life,
infants also undergo ‘mini-puberty’, a period in which male
infants produce pubertal levels of androgen. This temporal
overlap suggests the possibility that the neonatal androgen surge
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may promote Aire expression at a time when Aire function is
critical, thus ensuring protection from autoimmune disease
development.
Androgen is known to have multiple effects on the thymus.
Castration of male mice is associated with thymic enlargement,
whereas androgen replacement reduces thymic size41.
Interestingly, hypogonadal men have increased thymic output
of T cells, which is reversed with androgen administration42.
Furthermore, androgen administration has been associated with
increased thymocyte apoptosis43,44. These findings are consistent
with our findings that androgens enhance thymocyte negative
selection by upregulating Aire expression and peripheral self-
antigen expression. Whether increased negative selection
accounts for all or part of the increased thymocyte apoptosis
seen in androgen-treated mice remains to be determined. In the
setting of thymic injury, such as bone marrow transplantation
(BMT), androgen depletion has been reported to protect TECs
and promote subsequent T-cell immune reconstitution. For
instance, androgen blockade and keratinocyte growth factor in
combination protects TEC subsets from depletion during BMT,
suggesting that androgen blockade may have cytoprotective
effects in the setting of thymic injury45. Androgen blockade
also enhanced the efficacy of BMT as a tolerizing strategy for
EAE. This enhancement appeared to be mediated by androgen’s
promotion of thymic regeneration and subsequent immune
reconstitution46. Thus, in the setting of BMT, androgen appears
to play an important role in cytoprotection and regeneration
of TECs.
We propose a model in which androgen quantitatively
upregulates Aire expression, and that androgen levels in males
may increase Aire expression to a degree that protects against
autoimmunity. Such a quantitative model of androgen effects
leaves open the possibility that other factors may contribute to
protection against autoimmunity in males. Furthermore, it should
be noted that Aire-deficient female mice, compared with male
mice, continue to develop certain autoimmune diseases at an
increased incidence. Thus, other sex-associated factors are likely
to influence autoimmune disease incidence or severity in an
Aire-independent manner. In addition to androgen, other
hormones also vary between males and females, and may
contribute to differences in autoimmune susceptibility. Higher
oestrogen levels, for example, may increase autoimmune
susceptibility in females. Oestrogen has been reported to have
multiple immune effects, including altering CD4 to CD8 T-cell
ratios, increasing B-cell survival and increasing B-cell antibody
production, depending on the concentration and other factors47.
Similarly, differences in progesterone levels may also alter
immune function in females versus males48. Interestingly, a
recent study reported that the mTEC transcriptome is not
different between male and female mice49, a finding which seems
to conflict with our results. Furthermore, in this study, mTECs
from castrated males expressed increasesd Aire-dependent TSAs,
with similar levels of Aire, compared with intact mice. A potential
explanation for this discrepancy may be the age of the mice;
the latter study utilized 24-week-old mice, whereas we studied
6–8-week-old mice. Thus, the contributions of sex hormones to
autoimmune susceptibility are likely multiple and complex.
Whether additional hormones besides androgens may impinge
on Aire expression to alter immune function, and the effect of age
on these alterations, remains to be determined.
Aire prevents autoimmunity by promoting the transcription
of peripheral TSAs within the thymus and negative selection of
self-reactive T cells6. In the general population, Aire mRNA
levels vary greatly between individuals and are strongly
correlated with TSA expression in the thymus13. What
determines Aire transcription levels, however, is not
completely understood. To date, putative binding sites for Sp1,
NF-Y and AP-1 transcriptional complexes within the Aire
promoter have been identified26. In addition, the Ets family of
transcription factors has been implicated in positive regulation
of Aire transcription50. Our studies provide evidence that
androgen/AR complexes also associate with the Aire promoter
to upregulate Aire promoter activity. Interestingly, members of
the Ets family of transcription factors have been reported to
interact with AR in regulating transcriptional activity51,52. Thus,
it is plausible that androgen/AR complexes interact with Ets
family members or other transcription factors in mTECs to
control Aire transcription. An important caveat to keep in mind
is that a subset of our experiments was performed in non-mTEC
(LNCaP and HEK293) cell lines. This concern is tempered by
the use of transfected HEK293 cells to understand mechanisms
of Aire function53,54.
In addition to promoting thymic negative selection of
autoreactive thymocytes through TSA upregulation, Aire also
prevents autoimmunity through additional mechanisms. For
instance, several studies have suggested that Aire may promote
thymic negative selection through TSA-independent mechan-
isms9,55. In particular, Aire may regulate processing or
presentation of TSAs by thymic antigen-presenting cells or
expression of chemokines important in thymic dendritic cell
recruitment. In addition, Aire plays a crucial role in thymic
development of regulatory T cells8, a T-cell subset with potent
immunoregulatory function. Finally, Aire is also expressed
in peripheral lymphoid organs and may upregulate a
complementary set of TSAs to enforce peripheral tolerance56.
It is currently not clear whether androgen modulation of Aire
Figure 4 | Androgen activates AR to target to the Aire promoter. (a) Top: representative immunofluorescence staining of frozen thymic section from an
8-week-old male mouse. Slides were scanned at  20 magnification, with cortex and medulla delineated by a white dotted line. Bottom: expansion of
bracketed area to focus on Aire (green), AR (red) and 4,6-diamidino-2-phenylindole nuclear (blue) staining. Arrows indicate cells co-expressing Aire and
AR. (b) Top: quantification of cells per thymic medulla area that are Aireþ (green) and Aireþ þARþ positive (yellow). DAPI delineates cell nuclei. Bottom:
quantification of AR co-expression within Aireþ cells in males and females. Data shown are averagesþ s.d. of four 0.04-mm2 areas. (c) Schematic
diagram of 14 predicted AR-binding sites (rectangles; numbers indicate position relative to Aire translational start site) within a 2.8-kb human AIRE gene
50 flanking region. (d) AR chromatin immunoprecipitation (ChIP) in LNCaP cells pretreated with 5 mM 5-Aza and 100ngml 1 trichostatin. Cells were
treated with 10 nM DHT (þ ) or vehicle control ( ). Quantitative PCR for AR or IgG control ChIP was performed over two positive control regions
(prostate-specific antigen promoter and enhancer)and two negative control regions ( 1,575 to  1,275 region upstream of Aire translational start site (1)
and Aire exon (2)). Three Aire 50 flanking regions containing predicted AR-binding sites were tested for AR accumulation. Numbers indicate base pairs
upstream of Aire translational start site. Data shown are representative of three independent experiments performed. (e) AIRE promoter activity measured
by luciferase. HEK293T cells were transiently transfected with pAP1235 human AIRE promoter–luciferase reporter plasmid and/or pCMV-AR in the
presence of the indicated DHT concentrations for 24 h. Data shown are representative of two independent experiments. (f) AIRE promoter activity, as
in e, but with four mutant AIRE promoter–luciferase constructs (Mut1, Mut2, Mut3 and Del) that alter predicted AR-binding sites in the 50 AIRE flanking
region (Supplementary Table 1). AR expression vector pCMV-ARD538–614 with a deletion of the AR DNA-binding domain (binding Mut) was also tested.
For all data sets, unpaired Student’s t-test was used for comparisons. Error bars represent s.e.m. *Po0.05. NS, not significant.
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Figure 5 | Androgen protects against EAE in an Aire-dependent manner. (a) Relative MOG mRNA expression in sorted WT and Aire-deficient
(AireGW/þ ) mTECs was determined by quantitative RT–PCR. Four mice were pooled per group, and data shown are representative of at least two
independent experiments. (b) Average clinical EAE scores of WT (left) or AireGW/þ (right) male mice implanted with DHT pellets or sham operated
following immunization with MOG35 55 peptide. n¼ 5 in each group. Shown is representative of three independent experiments. (c) Representative Luxol
Fast Blue-PAS-stained lumbar spinal cord sections fromWT (top panels) or Aire-deficient AireGW/þ (bottom panels) mice treated with placebo (sham) or
DHT pellet collected 35 days after MOG immunizations (nZ5 for each group). Box in 4 image indicates area shown in  10 image. Arrows indicate
inflammatory foci with demyelination. Scale bar, 200mm (4); 100mm ( 10). (d) Mean numbers of inflammatory foci and demyelinated area in WTand
AireGW/þ mice treated with placebo ( ) or DHT pellet. (e) Concentrations of IL-2 and IL-17 cytokine in supernatants of splenocytes cultured in the
presence of increasing amounts of MOG35 55 peptide. Splenocytes were isolated from WTor AireGW/þ mice treated with DHTor sham at day 35 after
EAE induction. Unpaired Student’s t-test was used in all data sets, except for survival curves in which Mann–Whitney U-test was utilized. Error bars
represent s.e.m. *Po0.05. NS, not significant.
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expression also affects these additional tolerance mechanisms,
and this question will be the subject of future investigations.
At this time, compounds that promote Aire expression as
potential therapies for autoimmunity do not exist. Our study
suggests that androgen therapy may directly enhance Aire
expression to protect against autoimmunity. Indeed, preliminary
studies have demonstrated androgen efficacy in multiple
sclerosis57,58, an autoimmune disease in which Aire regulates
thymic expression of the antigenic target MOG. Our study also
suggests that developing strategies to target androgen to the
thymus may provide benefit for autoimmunity while minimizing
virilizing side effects. Thus, findings from this study may help
direct the use of androgen in the treatment of autoimmunity.
Methods
Mice. ARTfm/Y mice on C57BL/6 background (JAX 001809), aged 4–8 weeks, were
purchased from the Jackson Laboratory, Bar Harbor, Maine. Male and female WT
mice and Aire-deficient (AireGW/þ ) littermates12 on C57BL/6 background, aged
6–12 weeks, were bred in a specific pathogen-free mouse colony. TRP-1 TCR Tg
RAG / mice harbour a transgene encoding a TCR specific for TRP-1 in the
context of MHCII on a recombinase-activating gene-deficient background28,59.
Male Tyrp1B-w TRP-1 TCR Tg RAG / mice on C57BL/6 background
(JAX 008684), aged 6–12 weeks, were purchased from the Jackson Laboratory, Bar
Harbor, Maine, and bred to female RAG / mice on C57BL/6 background, aged
6–12 weeks, in a specific pathogen-free mouse colony to generate TRP-1 TCR Tg
RAG / male mice with WT Tyrp1 gene, so that endogenous TRP-1 protein is
expressed. C57BL/6J (Stock 000664 JAX) male and female mice were purchased
at 6–8 weeks of age. Mice were used in accordance with guidelines from the
University of North Carolina at Chapel Hill Animal Care and Use Committee.
Experiments were conducted with the approval of the Animal Use and Care
Committees of the University of North Carolina at Chapel Hill.
Androgen treatment in vivo. Androgen treatment was performed using DHT
pellets or subcutaneous DHT injections. DHT pellets provide 0–10mg per 60 day
release (Innovative Research of America) and were implanted subcutaneously into
2-week-old TRP-1 TCR Tg RAG / on C57BL/6 background male mice as per
manufacturer’s instruction. Circulating DHT levels after implantation are shown in
Supplementary Fig. 8. Alternatively, DHT (Sigma) was dissolved in vegetable oil
(40mg per 0.1ml per mouse) and injected subcutaneously. For sham-operated
controls, mice were subjected to the same procedure except those that were not
administered a DHT pellet. For placebo pellet controls, mice were subjected to the
same procedure and administered a placebo pellet.
Primary human and mouse thymus cell culture. Human neonatal thymus tissue
was obtained as surgical discards from cardiac surgery under protocols approved
by the Institutional Review Board at University of North Carolina at Chapel Hill.
Thymus was subjected to mechanical disruption, 0.125% collagenase/dispase and
0.1% DNase I digestion, and agitated with a Pasteur pipette continuously at 37 C
for 30min to break the clumps60. The fragments were then run on a Percoll density
gradient to separate the thymocytes and the TEC stromal fraction. The stromal
fraction was incubated in DMEM (Gibco) with 10% charcoal-stripped serum for
6 h in the presence of 10 nM DHT or vehicle control. For inhibitor studies,
flutamide (5 mM) or vehicle control was added to cultures for 2 h before 6-h
incubation with 10 nM DHT or vehicle control.
Quantitative RT–PCR. RNA was prepared from stromal fractions or flow-sorted
cell fractions using the RNeasy Mini Kit (Qiagen) and reverse transcribed
to complementary DNA. For a portion of human thymus specimens, fragments
of thymus tissue were flash-frozen before RNA preparation. Quantitative
RT–PCR was performed using previously reported primer/probe sets for
Aire and insulin60. Primer/probe sets for MOG (Mm00442688_m1), Trp-1
(Mm00453202_m1), tyrosinase (Mm00495817_m1), Silver (Mm00498996_m1),
Aire (Hs00230829_m1), AR (Mm00442688_m1; Hs00171172_m1), KRT5
(Hs00361185_m1), Krt10 (Mm03009921_m1), Csn2 (Mm04207885_m1),
Gad1 (Mm04207432_g1), Resp18 (Mm00485697_m1), Fabp9 (Mm01964336_s1),
Obp1a (Mm00500903_m1), Reg3b (Mm00440616_g1) and 18s (Hs99999901_s1)
were purchased from Applied Biosystems. Quantitative RT–PCR was performed
using a 7900HT Fast Real-Time PCR System (Applied Biosystems). The
housekeeping genes peptidylprolyl isomerase A (PPIA, cyclophilin A) or KRT5
were used as an internal control, since mRNA levels of PPIA and KRT5 are
androgen independent11,61. The standard curve method was used to analyse target
gene expression.
RNA sequencing of mTECs. Libraries (3.5 106 to 13.5 106 mapped reads per
sample) were generated from sorted mTECs (PI CD45 MHCIIþ Ly51low)
isolated from the TEC fraction, as described above with some modifications.
Ten mice were pooled per biologic replicate, with two biologic replicates per group
(male versus female). mTECs were pelleted, lysed in RLT lysis buffer (Qiagen) and
total RNA was recovered using the RNeasy Micro Kit (Qiagen). RNA quality and
concentration were assessed using the Experion high-sensitivity RNA analysis kit
(Bio-Rad). Complementary DNA libraries were prepared using the SMARTer Ultra
Low kit v3 (Clontech). Fifty-base pair reads were sequenced on an Illumina HiSeq
2000 through the UNC High Throughput Sequencing Core. Low-quality reads
were removed using Trimmomatic62 and the remaining reads were aligned to the
mm9 assembly of the mouse genome with the TopHat2 splice-junction mapper63.
Reads were assigned to genes using HTseq-count64. The normalized fragment
counts per transcript, RPKM (reads per kilobase of transcript per million
mapped reads), and the log fold changes were calculated by edgeR65. The heatmap
was generated by combining our RPKM values with those from the mature
Aire-positive and mature Aire knockout mTEC replicates from ref. 21
(GEO accession number GSE53111). The list of 3,980 Aire-regulated genes was
downloaded from the Supplementary Data that accompanied ref. 21. Of these,
2,760 (70%) were detected in our RNA sequencing experiments and used in the
heatmap (GEO accession number GSE79014).
Antibodies and flow cytometry. Antibodies used in this study were purchased
from eBioscience (CD4 (RM4–5)—catalogue no. 12-0042 used at 0.125 mg per test;
CD3 (145-2c11)—catalogue no. 250031 used at 1 mg per test; and Annexin V
catalogue no. 17–8007 used at 5 ml per test). CD8 (5H10)—catalogue no. MCD0830
used at 0.1 mg per test was purchased from ThermoFisher Scientific. Vb14 (14-2)—
catalogue no. 553258 used at 1 mg per test was purchased from BD Biosciences.
Cells were analysed on a Dako CyAn flow cytometer (Beckman-Coulter) using
FlowJo Software (TreeStar).
Immunofluorescence staining. Frozen thymic sections (8 mm) were acetone fixed
and immunostained as described12. Aire antibody (5H12; eBioscience used at 2.1 ml
per 100ml dilution solution), K5 antibody (Ab 53121; Abcam used at 0.001 ml per
100 ml dilution solution) and AR antibody (Ab 74272; Abcam used at 0.35 ml
per 100 ml dilution solution) staining was detected with biotinylated goat anti-rat
light chain (Millipore), phycoerythrin (PE)-conjugated donkey anti-rabbit IgG
(eBioscience) secondary antibodies and tertiary streptavidin-conjugated fluorescein
isothiocyanate (eBioscience). Slides were mounted in Dapi Fluoromount-G
(Southern Biotech).
The Aperio FL digital pathology scanning system was used to scan each whole-
mouse thymus section at a magnification of  20. This system allows fluorescent
whole-slide imaging of tissue sections at high resolution. Using ImageScope, the
ratio of Aireþ cells to K5þ medulla area was calculated as follows: four
600 600-mm sections of K5þ areas were randomly selected with the scorer
blinded to the presence Aire-positive cells in these areas. For each 0.36-mm2
region, the area of K5 was determined by tracing the outline of the medulla region,
excluding areas of black empty space. The number of Aire-positive green cells was
counted manually using the ImageScope Cell Counter tool. The average ratio of
Aireþ cells to K5þ area within the four sections were calculated per mouse. n¼ 4
mice per group.
Total mTEC cell numbers were determined by total counts obtained during
flow cytometric sorting for mTECs. Gating for mTECs was performed per20. n¼ 4
pooled mice in each group per replicate, with three replicates.
Transient transfections and luciferase reporter assays. HEK293T cells
(105 cells per well in 24-well plates) were transiently transfected with 0.3 mg each of
pAP1235 Aire promoter–luciferase reporter plasmid (a gift from Dr Part Peterson,
University of Tampere, Estonia)26, Renilla control vector and/or human AR
expression vector pCMV-AR66 using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions. After 48 h, luciferase activity measured using the
Dual-Luciferase Assay System (Promega) as per the manufacturer’s instruction.
Luciferase activity was normalized for transfection efficiency according to the
Renilla luciferase activity. Transfections were performed in triplicate. Mutant Aire
promoter DNA was synthesized by Genscript. Sequences of mutant AIRE
promoter–luciferase constructs (Mut1, Mut2, Mut3 and Del) that alter predicted
AR-binding sites in the 50 AIRE flanking promoter region are shown in
Supplementary Table 1. Mutant promoters were cloned into pGL4.70 vector
(Promega) containing hRluc reporter gene and constructs verified by sequencing.
Transcriptional activation assays. The metastatic human prostate cancer cell line
LNCaP (ATCC) was maintained in DMEM with 10% fetal bovine serum. The
DNA methyltransferase inhibitor 5-Aza was added to cells at final concentrations
from 0.5 to 20mM for 72 h. The deacetylase inhibitor tricostatin (0.1 mgml 1) was
added for 24 h alone or after 5-Aza treatment as indicated. Transcriptional
expression of Aire was determined by quantitative RT–PCR.
In vivo negative selection assay. Two-week-old TRP-1 TCR Tg RAG / mice
were injected with 20mg kg 1 acyline (provided by NIH/NICHD) and implanted
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with DHT pellets for 4 weeks. Apoptosis of CD4SP thymocytes was determined by
flow cytometry following annexin V staining.
Experimental autoimmune encephalitis. DHT pellets were implanted in 6-week-
old Aire-deficient AireGW/þ mice and WT control male mice, 4 weeks before EAE
induction. Mice were randomly assigned to the DHT or sham control groups. EAE
was induced in 10-week-old AireGW/þ mice and age-matched WT mice via
subcutaneous immunization with 0.1mg MOG p35–55 peptide in an emulsion
with complete Freund’s adjuvant. Mice were injected intravenously with 50 ng
Bordetella pertussis toxin at the time of and 2 days after immunization. Mice were
examined daily for clinical signs of EAE and scored on a 5 point scale: 0, no clinical
disease; 1, limp tail; 2, hindlimb weakness; 3, complete hindlimb paralysis; 4,
hindlimb paralysis and some forelimb paralysis; and 5, moribund or dead.
No blinding was done in this experiment.
EAE histopathology. Mice were perfused with PBS and spinal cord was
removed as described67. Lumbar spinal cords were formalin-fixed, embedded in
paraffin, sectioned (5 mm) and stained with Luxol Fast Blue-PAS as described68.
Quantification of inflammatory foci and areas of demyelination were performed
as described69.
Chromatin immunoprecipitation. Chromatin immunoprecipitation was
performed as described70. LNCaP cells were grown in DMEM supplemented
with 10% charcoal–dextran-stripped fetal bovine serum. After 2 days of culture,
cells were treated with 5 mM 5-Aza and 100 ngml 1 trichostatin for 24 h followed
by 10 nM DHT treatment or vehicle control for 2 h. DNA and protein were
crosslinked with 1% formaldehyde. Cells were lysed with 1% SDS, 10mM EDTA,
50mM Tris-HCl, pH 8.1, and protease inhibitor cocktail (Roche Molecular
Biochemicals) and sonicated 12 times at 15 s each. Fragments of B200 bp were
visualized. Supernatants were collected and diluted in 1% Triton X-100, 2mM
EDTA, 150mM NaCl and 20mM Tris-HCl, pH 8.1, followed by immunoclearing
with 2 mg sheared salmon sperm DNA, 20 ml preimmune serum and protein
A-Sepharose (45ml of 50% slurry in 10mM Tris-HCl, pH 8.1, and 1mM EDTA)
for 2 h at 4 C. Immunoprecipitation was performed for 6 h or overnight at 4 C
with 5 mg of AR antibody (C-19, Santa Cruz) or control rabbit IgG (Santa Cruz).
After immunoprecipitation, 45 ml protein A-Sepharose and 2 mg of salmon sperm
DNA were added, and the incubation was continued for another hour. Sepharose
beads were washed sequentially for 10min each in TSE I (0.1% SDS, 1% Triton
X-100, 2mM EDTA, 20mM Tris-HCl, pH 8.1, and 150mM NaCl), TSE II
(0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-HCl, pH 8.1, and 500mM
NaCl) and buffer III (0.25M LiCl, 1% NP-40, 1% deoxycholate, 1mM EDTA, and
10mM Tris-HCl, pH 8.1). Beads were washed three times with TE buffer and
extracted three times with 1% SDS, 0.1M NaHCO3. Eluates were pooled and
heated at 65 C for 6 h or overnight to reverse the formaldehyde crosslinking. DNA
fragments were purified with a QIAquick Spin Kit (Qiagen) and analysed for the
presence of Aire promoter DNA by quantitative PCR. The primers are listed in
Supplementary Table 4. PCR conditions were 94 C for 3min, (94 C 30 s, 60 C
30 s and 72 C 30 s) for 36 cycles, and 72 C for 10min.
Statistics. PRISM 5.0 and Microsoft Office Excel software were used to analyse the
data (GraphPad Software, Inc.). Unpaired two-tailed Student’s t-tests were used to
compare differences between the two groups. Sample sizes were determined by
power analysis based on estimated sample variances. Survival curves were
compared by Mann–Whitney U-test. P values of r0.05 were considered
significant. All data are expressed as the means±s.e.m., except where indicated.
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